Companies: 10,795·Total market cap: $144.5T
COMPASS Pathways plc

COMPASS Pathways plc

CMPSNASDAQHealthcare● Active
$12.11
$-0.94(-7.20%)
Market Cap$1.2B
P/E Ratio
52W High$14.76
52W Low$2.25

COMPASS Pathways plc (CMPS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CMPS · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was −$157.2M for FY2025 (fiscal year ending 2025-12-31), down 31.9% year-over-year

FY2025 Free Cash Flow−$157.2M▼ -31.9% YoY
Trailing 12M (TTM)−$159.5Mtrailing 4 quarters sum
FCF Margin
3-Year CAGRN/AN/A — contains negative FCF
5-Year CAGRN/AN/A — contains negative FCF
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
cmps free cash flow history · cmps free cash flow chart · cmps free cash flow growth rate · cmps free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest−$157.2M▼ 31.9%
FY2024−$119.2M▼ 22.3%
FY2023−$97.4M▲ +8.1%
FY2022−$106.0M▼ 55.8%
FY2021−$68.1M▼ 64.0%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
cmps free cash flow 2025 · cmps free cash flow 2024 · cmps free cash flow 2023 · cmps operating cash flow

FCF valuation metrics

COMPASS Pathways plc (CMPS) reported negative free cash flow of −$0.16B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)
N/A
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
N/A
TTM FCF ÷ Shares Outstanding
Price / FCF
N/A
Share Price ÷ FCF per Share
EV / FCF (TTM)
N/A
Enterprise Value basis
!

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
cmps price to free cash flow · cmps free cash flow yield · cmps free cash flow per share · cmps price to cash flow ratio

Cash flow statement summary

For FY2025, COMPASS Pathways plc generated −$157.2M in operating cash flow and spent 0M in capital expenditures, yielding −$157.2M in free cash flow.

Operating Activities
−$157.2M
Cash from core business operations
2025-12-31
Investing Activities
+$0.0M
CapEx, acquisitions & investments
2025-12-31
Financing Activities
+$140.7M
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF (−$157.2M) − |CapEx| (0M) = FCF (−$157.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
cmps cash flow statement · cmps cash flow statement 2025 · cmps operating cash flow · cmps cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
COMPASS Pathways plc
COMPASS Pathways plcYOU
CMPS
−$157.2M-31.9%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

COMPASS Pathways plc (CMPS) reported free cash flow of −$157.2M for FY2025 (fiscal year ending 2025-12-31), down 31.9% year-over-year.

COMPASS Pathways plc has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 8 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

CMPS free cash flow · 8 questions

COMPASS Pathways plc free cash flow was −$157.2M for FY2025, down 31.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$159.5M.

CMPS free cash flowCMPS FCFCMPS FCF 2025CMPS free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · COMPASS Pathways plc · COMPASS Pathways plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026